ClearBridge Investments
BNR

ClearBridge Investments’s Burning Rock Biotech BNR Stock Holding History

ClearBridge Investments’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,367
Closed -$906K – 829
2021
Q1 		$906K Sell
3,367
-16,633
-83% -$5.06M ﹤0.01% 697
2020
Q4 		$4.62M Buy
+20,000
New +$5.37M ﹤0.01% 589

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

ClearBridge Investments's BNR Position: Q2 2021 in Review

ClearBridge Investments sold out of Burning Rock Biotech (BNR) in Q2 2021, closing a stake of 3,367 shares — an estimated $906K sold.

ClearBridge Investments first reported a position in BNR in Q4 2020 and held it in 2 quarters. The position peaked at $4.62M in Q4 2020. 85 funds tracked by Wall St. Rank hold BNR as of Q2 2021.

  • ClearBridge Investments reported no remaining Burning Rock Biotech position as of Q2 2021 after selling out during the quarter.
  • ClearBridge Investments sold 3,367 Burning Rock Biotech shares in Q2 2021, an estimated $906K.
  • ClearBridge Investments first reported a position in Burning Rock Biotech in Q4 2020 and held it in 2 quarters.
  • ClearBridge Investments's Burning Rock Biotech position peaked at $4.62M in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2021.

Based on ClearBridge Investments's 13F filing for Q2 2021, filed 13 Aug 2021.